Espaņol (soon!) - October 11, 2008
CMEonHIV.com is dedicated to providing online CME presentations (slides with voiceover) on HIV/AIDS for healthcare professionals given by local and international experts to keep you up-to-date on the ongoing developments in the field.
  Biography  

Pr. Richard Harrigan

Current Position
Director, Research Laboratories, BC Centre for Excellence in HIV/AIDS

Primary Area of Interest
Viral and human factors associated with response to HIV therapy

Medical Training
PhD Biochemistry, University of British Columbia

Post-Graduate Training
Wellcome Foundation

Recent Publications
- Harrigan PR, Montaner JS, Wegner SA, Verbiest W, Miller V, Wood R, Larder BA. World-wide variation in HIV-1 henotypic susceptibility in untreated individuals: biologically relevant values for resistance testing. AIDS 2001;15(13):1671-7.
- Brumme ZL, Chan KJ, Dong W, Hogg R, O'Shaughnessy MV, Montaner JS, Harrigan PR. CCR5Delta32 and promoter polymorphisms are not correlated with initial virological or immunological treatment response. AIDS 2001 15(17):2259-66.
- Quayle WC, Peck LS, Peat H, Ellis-Evans JC, Harrigan PR. Extreme responses to climate change in antactic lakes. Science. 2002 (295):645.
 
  List of presentations from this healthcare provider available on CMEonHIV :

Genotypic and Phenotypic Tests for HIV Drug Resistance
Resistance Testing
Trends in HIV Drug Resistance Testing
  Login

  Please log in and get access to thousands of resources about HIV disease and its treatment.
 
Already a member?
  Username :
  Password :
   
 
  Lost your password?


  Search our database
  Find the information that you are looking for in over +3000 resources.
 
web cmeonhiv.com



CMEonHIV is owned by E-MedHosting.com.

Copyright @ 2002-2008 E-MedHosting.com. All rights reserved.  Disclaimer  |  Sponsor Disclaimer


USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR
BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.
C-Reactive Protein (CRP)